IL6 and Parkinson disease: Treatment with PG50 and l-dopa recorded a significant decrease in IL-6 levels by 70.84% and 105.72%, respectively, while TNF-α levels reached 572.79% and 723%, respectively in comparison to the PD rats (Table 4).